Literature DB >> 26041014

Placental magnetic resonance imaging T2* measurements in normal pregnancies and in those complicated by fetal growth restriction.

M Sinding1, D A Peters2, J B Frøkjaer3, O B Christiansen1, A Petersen4, N Uldbjerg5, A Sørensen1.   

Abstract

OBJECTIVES: The magnetic resonance imaging (MRI) variable transverse relaxation time (T2*) depends on multiple factors, one important one being the presence of deoxyhemoglobin. We aimed to describe placental T2* measurements in normal pregnancies and in those with fetal growth restriction (FGR).
METHODS: We included 24 normal pregnancies at 24-40 weeks' gestation and four FGR cases with an estimated fetal weight below the 1(st) centile. Prior to MRI, an ultrasound examination, including Doppler flow measurements, was performed. The T2* value was calculated using a gradient echo MRI sequence with readout at 16 different echo times. In normal pregnancies, repeat T2* measurements were performed and interobserver reproducibility was assessed in order to estimate the reproducibility of the method. Placental histological examination was performed in the FGR cases.
RESULTS: The method was robust regarding the technical and interobserver reproducibility. However, some slice-to-slice variation existed owing to the heterogeneous nature of the normal placenta. We therefore based T2* estimations on the average of two slices from each placenta. In normal pregnancies, the placental T2* value decreased significantly with increasing gestational age, with mean ± SD values of 120 ± 17 ms at 24 weeks' gestation, 84 ± 16 ms at 32 weeks and 47 ± 17 ms at 40 weeks. Three FGR cases had abnormal Doppler flow, histological signs of maternal hypoperfusion and a reduced T2* value (Z-score < -3.5). In the fourth FGR case, Doppler flow, placental histology and T2* value (Z-score, -0.34) were normal.
CONCLUSIONS: The established reference values for placental T2* may be clinically useful, as T2* values were significantly lower in FGR cases with histological signs of maternal hypoperfusion.
Copyright © 2015 ISUOG. Published by John Wiley & Sons Ltd. Copyright © 2015 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  MRI; T2*; fetal growth restriction; placenta; reproducibility; transverse relaxation time

Mesh:

Year:  2016        PMID: 26041014     DOI: 10.1002/uog.14917

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  19 in total

Review 1.  Placental MRI: Developing Accurate Quantitative Measures of Oxygenation.

Authors:  Esra Abaci Turk; Jeffrey N Stout; Christopher Ha; Jie Luo; Borjan Gagoski; Filiz Yetisir; Polina Golland; Lawrence L Wald; Elfar Adalsteinsson; Julian N Robinson; Drucilla J Roberts; William H Barth; P Ellen Grant
Journal:  Top Magn Reson Imaging       Date:  2019-10

2.  Evaluation of a motion-robust 2D chemical shift-encoded technique for R2* and field map quantification in ferumoxytol-enhanced MRI of the placenta in pregnant rhesus macaques.

Authors:  Ante Zhu; Scott B Reeder; Kevin M Johnson; Sydney M Nguyen; Thaddeus G Golos; Ann Shimakawa; Matthias R Muehler; Christopher J Francois; Ian M Bird; Sean B Fain; Dinesh M Shah; Oliver Wieben; Diego Hernando
Journal:  J Magn Reson Imaging       Date:  2019-07-05       Impact factor: 4.813

3.  Visual assessment of the placenta in antenatal magnetic resonance imaging across gestation in normal and compromised pregnancies: Observations from a large cohort study.

Authors:  Alison Ho; Lucy C Chappell; Lisa Story; Mudher Al-Adnani; Alexia Egloff; Emma Routledge; Mary Rutherford; Jana Hutter
Journal:  Placenta       Date:  2021-10-14       Impact factor: 3.481

4.  Volumetric Parameterization of the Placenta to a Flattened Template.

Authors:  S Mazdak Abulnaga; Esra Abaci Turk; Mikhail Bessmeltsev; P Ellen Grant; Justin Solomon; Polina Golland
Journal:  IEEE Trans Med Imaging       Date:  2022-04-01       Impact factor: 11.037

5.  3D R 2 * mapping of the placenta during early gestation using free-breathing multiecho stack-of-radial MRI at 3T.

Authors:  Tess Armstrong; Dapeng Liu; Thomas Martin; Rinat Masamed; Carla Janzen; Cass Wong; Teresa Chanlaw; Sherin U Devaskar; Kyunghyun Sung; Holden H Wu
Journal:  J Magn Reson Imaging       Date:  2018-08-24       Impact factor: 4.813

Review 6.  The application of in utero magnetic resonance imaging in the study of the metabolic and cardiovascular consequences of the developmental origins of health and disease.

Authors:  Stephanie A Giza; Simran Sethi; Lauren M Smith; Mary-Ellen E T Empey; Lindsay E Morris; Charles A McKenzie
Journal:  J Dev Orig Health Dis       Date:  2020-12-14       Impact factor: 2.401

7.  Structure-function relationships in the feto-placental circulation from in silico interpretation of micro-CT vascular structures.

Authors:  Monika Byrne; Rosalind Aughwane; Joanna L James; J Ciaran Hutchinson; Owen J Arthurs; Neil J Sebire; Sebastien Ourselin; Anna L David; Andrew Melbourne; Alys R Clark
Journal:  J Theor Biol       Date:  2021-02-17       Impact factor: 2.405

8.  Combined diffusion-relaxometry MRI to identify dysfunction in the human placenta.

Authors:  Paddy J Slator; Jana Hutter; Marco Palombo; Laurence H Jackson; Alison Ho; Eleftheria Panagiotaki; Lucy C Chappell; Mary A Rutherford; Joseph V Hajnal; Daniel C Alexander
Journal:  Magn Reson Med       Date:  2019-03-18       Impact factor: 4.668

9.  Multi-modal functional MRI to explore placental function over gestation.

Authors:  Jana Hutter; Paddy J Slator; Laurence Jackson; Ana Dos Santos Gomes; Alison Ho; Lisa Story; Jonathan O'Muircheartaigh; Rui P A G Teixeira; Lucy C Chappell; Daniel C Alexander; Mary A Rutherford; Joseph V Hajnal
Journal:  Magn Reson Med       Date:  2018-09-21       Impact factor: 4.668

10.  APPLAUSE: Automatic Prediction of PLAcental health via U-net Segmentation and statistical Evaluation.

Authors:  Maximilian Pietsch; Alison Ho; Alessia Bardanzellu; Aya Mutaz Ahmad Zeidan; Lucy C Chappell; Joseph V Hajnal; Mary Rutherford; Jana Hutter
Journal:  Med Image Anal       Date:  2021-06-23       Impact factor: 8.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.